Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

Neurological Diagnostic And Monitoring Equipment Market

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive And Non-Invasive), By Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Devices (Eeg), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Others), By Indication (Traumatic Brain Injuries, Epilepsy, Stroke, And Others), By End-User (Hospitals, Diagnostic & Imaging Centers, And Others), By Geography is expected to grow at a static CAGR forecast till 2026 due to advances in product portfolio and burgeoning neurological disorder prevalence among the aging population.

 

The global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.12 billion in 2020, growing at a CAGR of 6.70% during the forecast period from 2021 to 2026, and will reach USD 16.39 billion by 2026. The rise in demand for Neurological Diagnostic and Monitoring Equipment is primarily motivated by the increasing prevalence of neurological disorders along with the rising aging population, growing incidence of traumatic brain injuries, technological advancement in the product portfolio, the rising government initiatives to raise awareness among patient regarding neurological disorders and their early diagnosis for proper management, among others.

Neurological Diagnostic and Monitoring Equipment Market Dynamics:

The Global Neurological Diagnostic and Monitoring Equipment Market growth is burgeoning due to the rising prevalence of neurological disorders such as epilepsy, stroke, Parkinson’s among others across the globe. According to WHO 2021, epilepsy is a chronic brain disorder that accounts for a significant proportion of the world’s disease burden by affecting around 50 million people across the globe with 80% of the cases in low and middle-income nations. Also, the report mentions that an estimated 70% of people with epilepsy could be seizure-free if properly diagnosed and treated. Moreover, the incidence of brain tumors and cancer among the world population is also on a rise. For instance, as per the Global Cancer Observatory 2020 statistics, there were 308,102 new cases of brain and central nervous system cancer new cases in the year 2020. Therefore, the rising patient population and the need for early diagnosis of these disorders could increase the demand for neurodiagnostic and monitoring devices which further is expected to boost the global neurological diagnostic and monitoring equipment market.

 

Further, product approval of technologically advanced neurodiagnostic devices is likely to upsurge the global Neurological Diagnostic and Monitoring Equipment Market. For instance, recently in January 2020, Compumedics Limited received US FDA approval for Orion LifeSpanTM MEG with patented double relaxation oscillator superconducting quantum interference device (DROS; SQUID) sensor system.

 

However, certain factors such as dearth of skilled professionals and the high cost of surgery and devices for brain monitoring are major factors limiting the global demand for neurological diagnostic and monitoring equipment, especially in developed countries with low reimbursement policies.

Neurological Diagnostic and Monitoring Equipment Market Segment Analysis:

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), By Product Type (Magneto-Encephalography Devices (MEG), Electroencephalography Devices (EEG), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, Others), By Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), By End User (Hospitals, Diagnostic & Imaging Centers, And Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

 

In Neurological Diagnostic and Monitoring Equipment product segment, Electroencephalography Devices (EEG) hold a significant market during the forecasted period. This is owing to the availability of standalone as well as portable EEG models with different channels such as 8, 21, 25, and 32, among others. Moreover, other factors that contribute to the growth of the EEG segment are the growing focus of manufacturers towards technological advancements, such as lightweight, portability, and acquisition of raw data simultaneously. Also, the increasing demand for portable devices for clinical practice and outdoor investigation is projected to augment the segment growth.

 

Furthermore, recently in 2019, Nihon Kohden launched VitalEEG™ to rapidly assess brain health in unconscious patients. The system provides both remote access functionality, so clinicians can assess critical information from anywhere in the hospital, and Bluetooth communication, eliminating the need for additional cables. Thus such product launches are also expected to fuel the segmental growth of the Neurological Diagnostic and Monitoring Equipment market during the forecasted period.

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment Market:

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment market during the forecast period. This domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

 

Further, In the United States, the presence of key market players such as Masimo Corporation, Compumedics Limited, and Natus Medical Incorporated, among others is likely to boost the Neurological Diagnostic and Monitoring Equipment market. Also, the growing incidence of traumatic brain injuries (TBI) in the region is expected to bolster the market. For instance, as per the CDC 2021 report, in 2019, there were nearly 61,000 TBI-related deaths in the US. Also, according to a study: Traumatic Brain Injury published in NCBI 2021 by Georges A. and Das J.M., in the US, approximately 1.7 million people suffer a traumatic brain injury, with adolescents between ages 15 and 19 and adults age 65 and older among the most likely to sustain a traumatic brain injury. In addition, according to the Brain Injury Canada 2021 report, TBI occurs at an annual rate of 500 out of 100,000 individuals and by 2031, traumatic brain injury (TBI) is expected to be among the most common neurological conditions affecting Canadians, along with Alzheimer's disease and other dementias, and epilepsy. Thus, rising TBI could be a potential factor for neurological diagnostic and monitoring market growth in the region as these devices are extensively used for the diagnosis of all kinds of brain-associated deformities for better treatment and management.

 

Moreover, an increase in product approval in the region is also a driving factor for the Neurological Diagnostic and Monitoring Equipment in the region. For instance, in August 2020, Masimo announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains. With this FDA clearance, O3 is now indicated for use in both cerebral and somatic applications, both in the U.S. and in CE mark countries, for all patient populations.

 

Thus, the aforementioned factors are likely to upsurge the market for Neurological Diagnostic and Monitoring Equipment in the region.

 

Furthermore, the Asia-Pacific region has the future potential growth for the Global Neurological Diagnostic and Monitoring Equipment. This is due to the improving healthcare infrastructure, increasing per capita healthcare expenditure, rising disposable income, rising old age population coupled with increasing neurological disorders, and high rate of head injuries, among others.

Neurological Diagnostic and Monitoring Equipment Market Key Players:

Some of the key market players operating in the Neurological Diagnostic and Monitoring Equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc. , Recorders & Medicare Systems Pvt Ltd (RMS), Rimed , Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

Recent Developmental Activities in the Neurological Diagnostic and Monitoring Equipment Market:

  • In March 2021, Brain Scientific received FDA Clearance for Next-Gen NeuroCap™ EEG Headset, an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where the recording of STAT EEGs is desired.
  • In October 2020, MEGIN announced Japan Expansion by launching MEGIN KK in Tokyo.
  • In December 2019, Raumedic, a medical technology manufacturer, launched a new home-use device, named Raumed Home ICP, for intracranial pressure (ICP) monitoring. The product was developed for patients suffering from hydrocephalus.
  • Key Takeaways from the Neurological Diagnostic and Monitoring Equipment Market Report Study

  • Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurological Diagnostic and Monitoring Equipment market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the Global Neurological Diagnostic and Monitoring Equipment Market.
  • Various opportunities available for the other competitor in the Neurological Diagnostic and Monitoring Equipment Market space.
  • What are the top-performing segments in 2020? How these segments will perform in 2026.
  • Which are the top-performing regions and countries in the current market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neurological Diagnostic and Monitoring Equipment market growth in the coming future?

Target Audience who can be benefited from Neurological Diagnostic and Monitoring Equipment Market Report Study

  • Neurological Diagnostic and Monitoring Equipment providers
  • Research organizations and consulting companies
  • Neurological Diagnostic and Monitoring Equipment-related organization, association, forum, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders in Neurological Diagnostic and Monitoring Equipment
  • Various End-users who want to know more about the Neurological Diagnostic and Monitoring Equipment Market and the latest technological developments in the Neurological Diagnostic and Monitoring Equipment market.

Frequently Asked Questions for Neurological Diagnostic and Monitoring Equipment Market:

1. What is Neurological Diagnostic and Monitoring Equipment?

Neurological Diagnostic and Monitoring Equipment are the devices used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, among others. There are various equipment available in the market such as EEG, MEG, Cerebral Oximeters, among others.

 

2. What is the market for Global Neurological Diagnostic and Monitoring Equipment?

Global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.12 billion in 2020, growing at a CAGR of 6.70% during the forecast period from 2021 to 2026, in order to reach USD 16.39 billion by 2026.

 

3. What are the drivers for Global Neurological Diagnostic and Monitoring Equipment?

The major factors driving the demand for Neurological Diagnostic and Monitoring Equipment are the growing prevalence of neurological disorders coupled with the rising geriatric population, increasing incidence of traumatic brain injuries, and the launch of technically advanced products in the market.

 

4. What are the key players operating in Global Neurological Diagnostic and Monitoring Equipment?

Some of the key market players operating in the Neurological Diagnostic and Monitoring Equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft,  Brain Scientific, Inc. , Recorders & Medicare Systems Pvt Ltd (RMS), Rimed , Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

 

5. Which region has the highest share in Neurological Diagnostic and Monitoring Equipment market?

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment market during the forecast period, 2021-2026. This domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

1. Neurological Diagnostic and Monitoring Equipment Report Introduction

2. Neurological Diagnostic and Monitoring Equipment Executive summary

2.1. Scope of the Study

2.2. Market at Glance

2.3. Competitive Assessment

2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

3.1. The United States

3.2. Europe

3.2.1. Germany

3.2.2. France

3.2.3. Italy

3.2.4. Spain

3.2.5. U.K.

3.3. Japan

4. Neurological Diagnostic and Monitoring Equipment Market Key factors analysis

4.1. Neurological Diagnostic and Monitoring Equipment Market Drivers

4.1.1. Increasing prevalence of neurological disorders coupled with the rising aging population

4.1.2. Growing Incidence of Traumatic Brain Injuries

4.1.3. Technological advancement in the product portfolio

4.1.4. Rising government initiative to raise awareness among patients regarding neurological disorders and their early diagnosis for proper management

4.2. Neurological Diagnostic and Monitoring Equipment Market Restraints and Challenges

4.2.1. High cost of the devices and procedure

4.2.2. The dearth of Skilled Labours

4.3. Neurological Diagnostic and Monitoring Equipment Market Opportunities

4.3.1. Growing demand for non-invasive devices

4.3.2. Market growth opportunities in developing nations

5. Neurological Diagnostic and Monitoring Equipment Porter’s Five Forces Analysis

5.1. Bargaining Power of Suppliers

5.2. Bargaining Power of Consumers

5.3. Threat of New Entrants

5.4. Threat of Substitutes

5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Neurological Diagnostic and Monitoring Equipment Market

7. Neurological Diagnostic and Monitoring Equipment Market layout

7.1. By Type

7.1.1. Invasive

7.1.2. Non-invasive

7.2. By Product Type

7.2.1. Magnetoencephalography Devices (MEG)

7.2.2. Electroencephalography Devices (EEG)

7.2.3. Transcranial Doppler Sonography Devices

7.2.4. Cerebral Oximeters

7.2.5. Intracranial Pressure Monitors

7.2.6. Others

7.3. By Indication

7.3.1. Epilepsy

7.3.2. Traumatic Brain Injuries

7.3.3. Stroke

7.3.4. Others

7.4. By End-user

7.4.1. Hospitals

7.4.2. Diagnostic & Imaging Centers

7.4.3. Others

7.5. By Geography

7.5.1. North America

7.5.1.1. North America Neurological Diagnostic and Monitoring Equipment Market, by Type

7.5.1.2. North America Neurological Diagnostic and Monitoring Equipment Market, by Product Type

7.5.1.3. North America Neurological Diagnostic and Monitoring Equipment Market, by Indication

7.5.1.4. North America Neurological Diagnostic and Monitoring Equipment Market, by End User

7.5.1.5. North America Neurological Diagnostic and Monitoring Equipment Market, by Country

7.5.1.5.1. United States

7.5.1.5.2. Canada

7.5.1.5.3. Mexico

7.5.2. Europe

7.5.2.1. Europe Neurological Diagnostic and Monitoring Equipment Market, by Type

7.5.2.2. Europe Neurological Diagnostic and Monitoring Equipment Market, by Product Type

7.5.2.3. Europe Neurological Diagnostic and Monitoring Equipment Market, by Indication

7.5.2.4. Europe Neurological Diagnostic and Monitoring Equipment Market, by End User

7.5.2.5. Europe Neurological Diagnostic and Monitoring Equipment Market, by Country

7.5.2.5.1. France

7.5.2.5.2. Germany

7.5.2.5.3. United Kingdom

7.5.2.5.4. Italy

7.5.2.5.5. Spain

7.5.2.5.6. Russia

7.5.2.5.7. Rest of Europe

7.5.3. Asia-Pacific

7.5.3.1. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market, by Type

7.5.3.2. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market, by Product Type

7.5.3.3. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market, by Indication

7.5.3.4. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market, by End User

7.5.3.5. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market, by Country

7.5.3.5.1. China

7.5.3.5.2. Japan

7.5.3.5.3. India

7.5.3.5.4. Australia

7.5.3.5.5. South Korea

7.5.3.5.6. Rest of Asia Pacific

7.5.4. Rest of the World (RoW)

7.5.4.1. RoW Neurological Diagnostic and Monitoring Equipment Market, by Type

7.5.4.2. RoW Neurological Diagnostic and Monitoring Equipment Market, by Product Type

7.5.4.3. RoW Neurological Diagnostic and Monitoring Equipment Market, by Indication

7.5.4.4. RoW Neurological Diagnostic and Monitoring Equipment Market, by End User

7.5.4.5. RoW Neurological Diagnostic and Monitoring Equipment Market, by Region

7.5.4.5.1. Middle East

7.5.4.5.2. Africa

7.5.4.5.3. South America

8. Neurological Diagnostic and Monitoring Equipment Global Company Share Analysis – Key 3-5 Companies

9. Neurological Diagnostic and Monitoring Equipment Company and Product Profiles

9.1. Natus Medical, Inc

9.1.1. Company Overview

9.1.2. Company Snapshot

9.1.3. Financial Overview

9.1.4. Product Listing

9.1.5. Entropy

9.2. Nihon Kohden Corporation

9.2.1. Company Overview

9.2.2. Company Snapshot

9.2.3. Financial Overview

9.2.4. Product Listing

9.2.5. Entropy

9.3. Koninklijke Philips N.V.

9.3.1. Company Overview

9.3.2. Company Snapshot

9.3.3. Financial Overview

9.3.4. Product Listing

9.3.5. Entropy

9.4. Compumedics Limited

9.4.1. Company Overview

9.4.2. Company Snapshot

9.4.3. Financial Overview

9.4.4. Product Listing

9.4.5. Entropy

9.5. Croton Healthcare

9.5.1. Company Overview

9.5.2. Company Snapshot

9.5.3. Financial Overview

9.5.4. Product Listing

9.5.5. Entropy

9.6. Ricoh

9.6.1. Company Overview

9.6.2. Company Snapshot

9.6.3. Financial Overview

9.6.4. Product Listing

9.6.5. Entropy

9.7. Elekta AB

9.7.1. Company Overview

9.7.2. Company Snapshot

9.7.3. Financial Overview

9.7.4. Product Listing

9.7.5. Entropy

9.8. Integra LifeSciences

9.8.1. Company Overview

9.8.2. Company Snapshot

9.8.3. Financial Overview

9.8.4. Product Listing

9.8.5. Entropy

9.9. RAUMEDIC AG

9.9.1. Company Overview

9.9.2. Company Snapshot

9.9.3. Financial Overview

9.9.4. Product Listing

9.9.5. Entropy

9.10. Masimo

9.10.1. Company Overview

9.10.2. Company Snapshot

9.10.3. Financial Overview

9.10.4. Product Listing

9.10.5. Entropy

9.11. Cadwell® Industries Inc.

9.11.1. Company Overview

9.11.2. Company Snapshot

9.11.3. Financial Overview

9.11.4. Product Listing

9.11.5. Entropy

9.12. Nonin

9.12.1. Company Overview

9.12.2. Company Snapshot

9.12.3. Financial Overview

9.12.4. Product Listing

9.12.5. Entropy

9.13. Neurosoft

9.13.1. Company Overview

9.13.2. Company Snapshot

9.13.3. Financial Overview

9.13.4. Product Listing

9.13.5. Entropy

9.14. Brain Scientific, Inc.

9.14.1. Company Overview

9.14.2. Company Snapshot

9.14.3. Financial Overview

9.14.4. Product Listing

9.14.5. Entropy

9.15. Recorders & Medicare Systems Pvt Ltd (RMS)

9.15.1. Company Overview

9.15.2. Company Snapshot

9.15.3. Financial Overview

9.15.4. Product Listing

9.15.5. Entropy

9.16. Rimed

9.16.1. Company Overview

9.16.2. Company Snapshot

9.16.3. Financial Overview

9.16.4. Product Listing

9.16.5. Entropy

9.17. Allengers

9.17.1. Company Overview

9.17.2. Company Snapshot

9.17.3. Financial Overview

9.17.4. Product Listing

9.17.5. Entropy

9.18. Medtronic

9.18.1. Company Overview

9.18.2. Company Snapshot

9.18.3. Financial Overview

9.18.4. Product Listing

9.18.5. Entropy

9.19. Edwards Lifesciences Corporation.

9.19.1. Company Overview

9.19.2. Company Snapshot

9.19.3. Financial Overview

9.19.4. Product Listing

9.19.5. Entropy

9.20. Ybrain, INC

9.20.1. Company Overview

9.20.2. Company Snapshot

9.20.3. Financial Overview

9.20.4. Product Listing

9.20.5. Entropy

10. Project Approach

10.1. Secondary Sources

10.2. Primary Sources

10.3. Data Triangulation

10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: COVID-19 Impact Analysis on Neurological Diagnostic and Monitoring Equipment Market

Table 3: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global (2018-2026)

Table 4: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Type (2018-2026)

Table 5: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Product Type (2018-2026)

Table 6: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Indication (2018-2026)

Table 7: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by End User (2018-2026)

Table 8: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Geography (2018-2026)

Table 9: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America (2018-2026)

Table 10: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Type (2018-2026)

Table 11: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Product Type (2018-2026)

Table 12: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Indication (2018-2026)

Table 13: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by End User (2018-2026)

Table 14: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Country (2018-2026)

Table 15: Neurological Diagnostic and Monitoring Equipment Market Analysis in the US (2018-2026)

Table 16: Neurological Diagnostic and Monitoring Equipment Market Analysis in Canada (2018-2026)

Table 17: Neurological Diagnostic and Monitoring Equipment Market Analysis in Mexico (2018-2026)

Table 18: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe (2018-2026)

Table 19: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Type (2018-2026)

Table 20: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Product Type (2018-2026)

Table 21: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Indication (2018-2026)

Table 22: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by End User (2018-2026)

Table 23: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Country (2018-2026)

Table 24: Neurological Diagnostic and Monitoring Equipment Market Analysis in France (2018-2026)

Table 25: Neurological Diagnostic and Monitoring Equipment Market Analysis in Germany (2018-2026)

Table 26: Neurological Diagnostic and Monitoring Equipment Market Analysis in the UK (2018-2026)

Table 27: Neurological Diagnostic and Monitoring Equipment Market Analysis in Italy (2018-2026)

Table 28: Neurological Diagnostic and Monitoring Equipment Market Analysis in Spain (2018-2026)

Table 29: Neurological Diagnostic and Monitoring Equipment Market Analysis in Russia (2018-2026)

Table 30: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of Europe (2018-2026)

Table 31: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific (2018-2026)

Table 32: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Type (2018-2026)

Table 33: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Product Type (2018-2026)

Table 34: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Indication (2018-2026)

Table 35: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by End User (2018-2026)

Table 36: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Country (2018-2026)

Table 37: Neurological Diagnostic and Monitoring Equipment Market Analysis in China (2018-2026)

Table 38: Neurological Diagnostic and Monitoring Equipment Market Analysis in Japan (2018-2026)

Table 39: Neurological Diagnostic and Monitoring Equipment Market Analysis in India (2018-2026)

Table 40: Neurological Diagnostic and Monitoring Equipment Market Analysis in Australia (2018-2026)

Table 41: Neurological Diagnostic and Monitoring Equipment Market Analysis in South Korea (2018-2026)

Table 42: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of Asia-Pacific (2018-2026)

Table 43: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World (2018-2026)

Table 44: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Type (2018-2026)

Table 45: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Product Type (2018-2026)

Table 46: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Indication (2018-2026)

Table 47: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by End User (2018-2026)

Table 48: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Country (2018-2026)

Table 49: Neurological Diagnostic and Monitoring Equipment Market Analysis in Middle East (2018-2026)

Table 50: Neurological Diagnostic and Monitoring Equipment Market Analysis in Africa (2018-2026)

Table 51: Neurological Diagnostic and Monitoring Equipment Market Analysis in South America (2018-2026)

List of Figures

Figure 1: Competitive Analysis

Figure 2: COVID-19 Impact Analysis on Neurological Diagnostic and Monitoring Equipment Market

Figure 3: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global (2018-2026)

Figure 4: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Type (2018-2026)

Figure 5: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Product Type (2018-2026)

Figure 6: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Indication (2018-2026)

Figure 7: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by End User (2018-2026)

Figure 8: Neurological Diagnostic and Monitoring Equipment Market Analysis in Global by Geography (2018-2026)

Figure 9: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America (2018-2026)

Figure 10: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Type (2018-2026)

Figure 11: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Product Type (2018-2026)

Figure 12: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Indication (2018-2026)

Figure 13: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by End User (2018-2026)

Figure 14: Neurological Diagnostic and Monitoring Equipment Market Analysis in North America by Country (2018-2026)

Figure 15: Neurological Diagnostic and Monitoring Equipment Market Analysis in the US (2018-2026)

Figure 16: Neurological Diagnostic and Monitoring Equipment Market Analysis in Canada (2018-2026)

Figure 17: Neurological Diagnostic and Monitoring Equipment Market Analysis in Mexico (2018-2026)

Figure 18: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe (2018-2026)

Figure 19: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Type (2018-2026)

Figure 20: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Product Type (2018-2026)

Figure 21: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Indication (2018-2026)

Figure 22: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by End User (2018-2026)

Figure 23: Neurological Diagnostic and Monitoring Equipment Market Analysis in Europe by Country (2018-2026)

Figure 24: Neurological Diagnostic and Monitoring Equipment Market Analysis in France (2018-2026)

Figure 25: Neurological Diagnostic and Monitoring Equipment Market Analysis in Germany (2018-2026)

Figure 26: Neurological Diagnostic and Monitoring Equipment Market Analysis in the UK (2018-2026)

Figure 27: Neurological Diagnostic and Monitoring Equipment Market Analysis in Italy (2018-2026)

Figure 28: Neurological Diagnostic and Monitoring Equipment Market Analysis in Spain (2018-2026)

Figure 29: Neurological Diagnostic and Monitoring Equipment Market Analysis in Russia (2018-2026)

Figure 30: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of Europe (2018-2026)

Figure 31: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific (2018-2026)

Figure 32: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Type (2018-2026)

Figure 33: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Product Type (2018-2026)

Figure 34: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Indication (2018-2026)

Figure 35: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by End User (2018-2026)

Figure 36: Neurological Diagnostic and Monitoring Equipment Market Analysis in Asia-Pacific by Country (2018-2026)

Figure 37: Neurological Diagnostic and Monitoring Equipment Market Analysis in China (2018-2026)

Figure 38: Neurological Diagnostic and Monitoring Equipment Market Analysis in Japan (2018-2026)

Figure 39: Neurological Diagnostic and Monitoring Equipment Market Analysis in India (2018-2026)

Figure 40: Neurological Diagnostic and Monitoring Equipment Market Analysis in Australia (2018-2026)

Figure 41: Neurological Diagnostic and Monitoring Equipment Market Analysis in South Korea (2018-2026)

Figure 42: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of Asia-Pacific (2018-2026)

Figure 43: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World (2018-2026)

Figure 44: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Type (2018-2026)

Figure 45: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Product Type (2018-2026)

Figure 46: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Indication (2018-2026)

Figure 47: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by End User (2018-2026)

Figure 48: Neurological Diagnostic and Monitoring Equipment Market Analysis in Rest of World by Country (2018-2026)

Figure 49: Neurological Diagnostic and Monitoring Equipment Market Analysis in Middle East (2018-2026)

Figure 50: Neurological Diagnostic and Monitoring Equipment Market Analysis in Africa (2018-2026)

Figure 51: Neurological Diagnostic and Monitoring Equipment Market Analysis in South America (2018-2026)

Figure 52: Market Drivers

Figure 53: Market Barriers

Figure 54: Maeket Opportunities

Figure 55: PORTER's Five Force Analysis

Natus Medical, Inc.
Nihon Kohden Corporation
Koninklijke Philips N.V.
Compumedics Limited
Croton Healthcare
Ricoh
Elekta AB
Integra LifeSciences
RAUMEDIC AG
Masimo, Cadwell® Industries Inc.
Nonin, Neurosoft
Brain Scientific, Inc.
Recorders & Medicare Systems Pvt Ltd (RMS)
Rimed
Allengers
Medtronic
Edwards Lifesciences Corporation
Ybrain, INC, and others

Forward to Friend

Need A Quote